Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.56 SEK | -0.12% | -5.37% | +7.12% |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Apr. 17 | Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US | CI |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB